MNMD Q3 2025 Earnings Results — Mind Medicine (MindMed) Inc. Common Shares
XNAS · Healthcare · Biotechnology
Updated
When is MNMD's next earnings date?
Mind Medicine (MindMed) Inc. Common Shares (MNMD) has not announced its next earnings date yet. Its most recent earnings report was on Thursday, November 6, 2025.
How did MNMD do in its last earnings report?
In its most recent report on Nov 6, 2025 (Q3 2025), Mind Medicine (MindMed) Inc. Common Shares posted EPS of -$0.78 versus the -$0.51 estimate, a miss of 52.9%. Revenue was $0. The stock's 1-day post-earnings move was +3.2%.
How much does MNMD stock move after earnings?
MNMD beat EPS estimates in 2 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 6.7% (up or down) in the day after earnings.
About Mind Medicine (MindMed) Inc. Common Shares
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2025-11-06 | Q3 2025 | -0.51 | -0.78 | -52.94% | $0 | ❌ Miss | +3.17% | +2.56% | +14.64% |
| 2025-07-31 | Q2 2025 | -0.37 | -0.50 | -35.14% | $0 | ❌ Miss | -7.15% | +9.90% | -2.31% |
| 2025-03-06 | Q4 2024 | -0.28 | -0.41 | -46.43% | $0 | ❌ Miss | +3.60% | +1.10% | -13.01% |
| 2024-11-07 | Q3 2024 | -0.28 | -0.27 | +3.57% | $0 | ✅ Beat | +12.90% | +11.57% | -3.13% |
| 2024-08-13 | Q2 2024 | -0.33 | -0.47 | -42.42% | $0 | ❌ Miss | -3.80% | -7.15% | -12.55% |
| 2024-05-08 | Q1 2024 | -0.47 | -1.14 | -142.55% | $0 | ❌ Miss | -5.10% | -5.62% | -24.56% |
| 2024-02-28 | Q4 2023 | -0.46 | -0.59 | -28.26% | $0 | ❌ Miss | -3.78% | +6.83% | +70.86% |
| 2023-11-02 | Q3 2023 | -0.67 | -0.45 | +32.84% | $0 | ✅ Beat | +14.44% | -5.93% | +33.70% |
Showing last 8 quarters.